Related Experiment Video
Updated: May 9, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Polypharmacology - foe or friend?
1F. Hoffmann-La Roche Ltd. , pRED, Pharma Research and Early Development, Discovery Chemistry, CH-4070 Basel, Switzerland.
Journal of Medicinal Chemistry
|August 8, 2013
Summary
Polypharmacology, a drug
Area of Science:
- Pharmacology and Drug Discovery
- Medicinal Chemistry
- Computational Biology
Background:
- Polypharmacology, the interaction of a compound with multiple biological targets, is a key consideration in drug development.
- Understanding polypharmacology is crucial for both mitigating adverse drug effects and enhancing therapeutic outcomes.
- Current research explores the dual nature of polypharmacology in drug safety and efficacy.
Purpose of the Study:
- To review the interconnected aspects of polypharmacology in drug discovery and development.
- To provide a balanced perspective on the risks and benefits of polypharmacology.
- To highlight opportunities for leveraging polypharmacology in treating complex diseases.
Main Methods:
- Review of existing literature on polypharmacology, drug safety, and therapeutic efficacy.
- Discussion of methods for identifying polypharmacological compounds during early drug discovery.
- Analysis of polypharmacology's role in treating multigenic diseases and infections.
Main Results:
- Unintended polypharmacology can lead to significant adverse drug effects.
- Strategic polypharmacology can improve therapeutic efficacy, combat drug resistance, and reduce side effects.
- Early identification of polypharmacological profiles is essential for drug safety.
Conclusions:
- Polypharmacology presents a double-edged sword: it can compromise drug safety but also offer superior therapeutic benefits.
- A balanced approach to understanding and managing polypharmacology is vital for successful drug discovery.
- Further research into polypharmacology can unlock new therapeutic strategies for complex diseases and infections.
Related Concept Videos
01:14Agonism and Antagonism: Quantification
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
01:30Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
01:21Pharmacodynamics: Overview and Principles
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:24Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...